Literature DB >> 19038344

The roles of chemokine CXCL12 in embryonic and brain tumor angiogenesis.

Meizhang Li1, Richard M Ransohoff.   

Abstract

The formation of blood vessels in embryos and tumors are different processes but under the control of common molecular mechanisms. Chemokine CXCL12 involved in both embryonic and tumor angiogenesis. In this review, we summarize recent advances in understanding the roles of CXCL12 in brain tumor angiogenesis/vasculogenesis. CXCL12 and its cognate receptors are abnormally induced in brain tumors, in particular in tumor cells and endothelium. Pathologically enhanced CXCL12 signaling may promote the formation of new vessels through recruiting circulating endothelial progenitor cells or directly enhancing the migration/growth of endothelial cells. Therefore, CXCL12 signaling represents an important mechanism that regulates brain tumor angiogenesis/vasculogenesis and may provide potential targets for anti-angiogenic therapy in malignant gliomas.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19038344     DOI: 10.1016/j.semcancer.2008.11.001

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  33 in total

Review 1.  Mechanisms of dendritic cell trafficking across the blood-brain barrier.

Authors:  Divya Sagar; Catherine Foss; Rasha El Baz; Martin G Pomper; Zafar K Khan; Pooja Jain
Journal:  J Neuroimmune Pharmacol       Date:  2011-08-06       Impact factor: 4.147

Review 2.  Developmental and pathological angiogenesis in the central nervous system.

Authors:  Mario Vallon; Junlei Chang; Haijing Zhang; Calvin J Kuo
Journal:  Cell Mol Life Sci       Date:  2014-04-24       Impact factor: 9.261

3.  The CCL2 chemokine is a negative regulator of autophagy and necrosis in luminal B breast cancer cells.

Authors:  Wei Bin Fang; Min Yao; Iman Jokar; Nabil Alhakamy; Cory Berkland; Jin Chen; Dana Brantley-Sieders; Nikki Cheng
Journal:  Breast Cancer Res Treat       Date:  2015-03-06       Impact factor: 4.872

Review 4.  Brain angiogenesis in developmental and pathological processes: mechanism and therapeutic intervention in brain tumors.

Authors:  Woo-Young Kim; Ho-Young Lee
Journal:  FEBS J       Date:  2009-07-31       Impact factor: 5.542

5.  Chemokine signaling in cancer: Implications on the tumor microenvironment and therapeutic targeting.

Authors:  Stacey L Hembruff; Nikki Cheng
Journal:  Cancer Ther       Date:  2009-04-14

6.  Blocking SDF-1α/CXCR4 downregulates PDGF-B and inhibits bone marrow-derived pericyte differentiation and tumor vascular expansion in Ewing tumors.

Authors:  Randala Hamdan; Zhichao Zhou; Eugenie S Kleinerman
Journal:  Mol Cancer Ther       Date:  2013-11-26       Impact factor: 6.261

7.  Expression of stromal cell-derived factor-1α is an independent risk factor for lymph node metastasis in early gastric cancer.

Authors:  Ik-Chan Song; Zhe-Long Liang; Jung-Chan Lee; Song-Mei Huang; Ha-Yon Kim; Yoon-Suk Oh; Hwan-Jung Yun; Ji-Young Sul; Deog-Yeon Jo; Samyong Kim; Jin-Man Kim; Hyo-Jin Lee
Journal:  Oncol Lett       Date:  2011-08-19       Impact factor: 2.967

8.  New treatment options in the management of glioblastoma multiforme: a focus on bevacizumab.

Authors:  Argirios Moustakas; Teri N Kreisl
Journal:  Onco Targets Ther       Date:  2010-06-24       Impact factor: 4.147

Review 9.  Chemokine receptor CXCR4 as a therapeutic target for neuroectodermal tumors.

Authors:  Hyunsuk Shim; Shinya Oishi; Nobutaka Fujii
Journal:  Semin Cancer Biol       Date:  2008-11-25       Impact factor: 15.707

10.  The role of macrophage class a scavenger receptors in a laser-induced murine choroidal neovascularization model.

Authors:  Shayma Jawad; Baoying Liu; Zhiyu Li; Robert Katamay; Mercedes Campos; Lai Wei; H Nida Sen; Diamond Ling; Fernando Martinez Estrada; Juan Amaral; Chi-Chao Chan; Robert Fariss; Siamon Gordon; Robert B Nussenblatt
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-09-05       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.